Finanças

Notícias Discussões Sinais técnicos Previsão Sazonais Opções

Resultado Operacional de Tarsus Pharmaceuticals, Inc..

Dados anuais

2019

2020

2021

2022

2023

2024

TTM

‪‪−160,00 M‬‬

‪‪−120,00 M‬‬

‪‪−80,00 M‬‬

‪‪−40,00 M‬‬

‪0,00‬

Período

Valor

Variação

Variação %

TTM

‪‪−120,57 M‬‬

‪0,00‬

‪0,00‬%

2024

‪‪−120,57 M‬‬

+‪‪22,59 M‬‬

+‪15,78‬%

2023

‪‪−143,16 M‬‬

‪‪−80,45 M‬‬

‪−128,28‬%

2022

‪‪−62,71 M‬‬

‪‪−50,55 M‬‬

‪−415,85‬%

2021

‪‪−12,16 M‬‬

+‪‪14,83 M‬‬

+‪54,95‬%

2020

‪‪−26,98 M‬‬

‪‪−22,68 M‬‬

‪−527,80‬%

2019

Dados trimestrais

Q1 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪‪−48,00 M‬‬

‪‪−36,00 M‬‬

‪‪−24,00 M‬‬

‪‪−12,00 M‬‬

‪0,00‬

Período

Valor

Variação

Variação %

Q4 '24

‪‪−24,42 M‬‬

+‪‪741,00 K‬‬

+‪2,94‬%

Q3 '24

‪‪−25,16 M‬‬

+‪‪8,14 M‬‬

+‪24,44‬%

Q2 '24

‪‪−33,30 M‬‬

+‪‪4,38 M‬‬

+‪11,63‬%

Q1 '24

‪‪−37,68 M‬‬

+‪‪6,77 M‬‬

+‪15,22‬%

Q4 '23

‪‪−44,45 M‬‬

‪‪−3,52 M‬‬

‪−8,59‬%

Q3 '23

‪‪−40,94 M‬‬

‪‪−8,11 M‬‬

‪−24,72‬%

Q2 '23

‪‪−32,82 M‬‬

‪‪−7,87 M‬‬

‪−31,54‬%

Q1 '23

‪‪−24,95 M‬‬

‪‪−9,89 M‬‬

‪−65,67‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q1 '20